Quitterer, Ursula, Prof. Dr.

Prof. Dr. Ursula Quitterer

Inst. f. Pharmazeutische Wiss. 

Y17  M 70 

Winterthurerstrasse 190

8057 Zürich

Switzerland

  • phone +41 44 635 60 01 
  • fax +41 44 635 68 81 
  • phone (Sec.) +41 44 635 60 02 
  • mail
  • vcard V-Card (vcf, 1kb)

Additional information

Curriculum Vitae

Ursula Quitterer is a Full Professor of Molecular Pharmacology in the Institute of Pharmaceutical Sciences at ETH Zurich since February 2006.



In 1966 Ursula Quitterer was born in Passau, Germany. She studied pharmaceutical sciences in Regensburg and obtained a Ph.D. degree in 1994 from the University of Mainz. After a postdoctorate at Roche Biosciences Inc. in Palo Alto (USA), she joined the Institute of Pharmacology at the University of Würzburg (Deutschland) as a senior scientist. In 1999 she was awarded the "Bayerische Habilitationsförderpreis". Research visits at Medigene Inc. (Munich) and at the Heinrich-Pette-Institute of Experimental Virology and Immunology (Hamburg) followed. She achieved the habilitation for pharmacology and toxicology in 2001. From 2004 to 2005 she directed the teaching program of pharmacology and toxicology for pharmaceutical and life science students at the University of Wuerzburg.



Research interests include the pathomechanisms of cardiovascular disease and atherosclerosis with particular focus on the relationship between cardiovascular risk factors, the dysfunction of signal transduction mechanisms and end organ damage. The research aims to identify pharmacological targets and to delineate therapeutic concepts to prevent and retard the progression of cardiovascular disease.

Course Catalogue

Photo-Quitterer

Curriculum Vitae

Ursula Quitterer is a Full Professor of Molecular Pharmacology in the Institute of Pharmaceutical Sciences at ETH Zurich since February 2006.

In 1966 Ursula Quitterer was born in Passau, Germany. She studied pharmaceutical sciences in Regensburg and obtained a Ph.D. degree in 1994 from the University of Mainz. After a postdoctorate at Roche Biosciences Inc. in Palo Alto (USA), she joined the Institute of Pharmacology at the University of Würzburg (Deutschland) as a senior scientist. In 1999 she was awarded the "Bayerische Habilitationsförderpreis". Research visits at Medigene Inc. (Munich) and at the Heinrich-Pette-Institute of Experimental Virology and Immunology (Hamburg) followed. She achieved the habilitation for pharmacology and toxicology in 2001. From 2004 to 2005 she directed the teaching program of pharmacology and toxicology for pharmaceutical and life science students at the University of Wuerzburg.

Research interests include the pathomechanisms of cardiovascular disease and atherosclerosis with particular focus on the relationship between cardiovascular risk factors, the dysfunction of signal transduction mechanisms and end organ damage. The research aims to identify pharmacological targets and to delineate therapeutic concepts to prevent and retard the progression of cardiovascular disease.

 
 
Page URL: https://www.chab.ethz.ch/en/the-department/people/faculty/person-detail.html
Tue Feb 28 00:04:32 CET 2017
© 2017 Eidgenössische Technische Hochschule Zürich